This bid is closed — responses were due July 16, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This is a grant opportunity (R03 Clinical Trial Not Allowed) under the HEAL Initiative for early-stage discovery of new pain targets within the understudied druggable proteome. The funding opportunity is PAR-25-154 and includes multiple CFDA numbers.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Early-Stage Discovery Research Services for New Pain Targets
1
project
$275,000.00
$275,000.00
Professional Services
Estimated Bid Value
$275,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.